GRIN2A and early-onset autosomal dominant Alzheimer disease: On the other hand, seizures caused by GoF mutations in the GRIN2A gene, encoding for the GluN2A subunits of NMDA receptors, can be treated with memantine, an NMDA receptor antagonist that was previously used in the treatment of Alzheimer’s disease.